用机器学习预测和优化用于乳腺癌治疗的协同药物组合
Dhyanendra Jain1, Kamal Upreti2, Tan Kuan Tak3
1Department of CSE-AIML, ABES Engineering College, Ghaziabad.
American journal of clinical oncology
|August 4, 2025
概括
机器学习准确地预测乳腺癌治疗的协同药物组合. 这种方法确定了像Ixabepilone+Cladribine这样的有前途的组合,加速了有效疗法的发现.
科学领域:
- 计算生物学是一种计算生物学.
- 药理学 药理学是指药理学的学科.
- 机器学习在瘤学中
背景情况:
- 乳腺癌的治疗依赖于有效的药物组合.
- 确定协同作用的药物组合对于提高治疗疗效至关重要.
- 药物协同效应查的传统方法耗时且资源密集.
研究的目的:
- 利用机器学习来准确预测乳腺癌中药物协同作用得分.
- 识别和排名具有高度协同作用的药物组合,以潜在的治疗用途.
- 为了加速乳腺癌组合疗法的药物发现过程.
主要方法:
- 利用机器学习模型 (XGBoost,随机森林,CatBoost) 来分析乳腺癌药物组合数据.
- 使用四个协同效应指标量化药物相互作用:ZIP,Bliss,Loewe和HSA.
- 使用规范化根平均平方误差 (NRMSE) 和皮尔森相关系数评估模型性能.
主要成果:
- XGBoost表现出卓越的性能,在Bliss协同效应模型中,NRMSE达到0.074和Pearson相关性为0.90.
- 确定了顶级的协同作用组合,包括Ixabepilone+Cladribine,SN 38乳+Pazopanib,以及Decitabine+Tretinoin.
- 基于高协同成绩和支持生物机制的验证顶级组合.
结论:
- 机器学习有效地预测乳腺癌的协同药物组合.
- 这种计算方法加速了选,减少了实验负担.
- 这些发现为指导未来新型组合疗法的体外和体内验证提供了有价值的工具.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.3K
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.3K
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K
Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
